Abstract
Proposes continuation of grant to study the effects of nicotine, metabolites and /or alkaloids on the Central Nervous System [CNS] of animals and humans. Indicates this is an important area of research and submits progress report. Reports behavioral and EEG changes in cats at the 5-10 microgm/kg of nicotine doseage and proposes further studies of nicotine and related alkaloids on the limbic, hypothalamic and cerebral cortex before and after the use of blocking drugs be used to correlate them with behavior. Says nicotine alkaloids in tobacco smoke and metabolites of nicotine including cotinine need further study and human studies will include normal human and selected psychiatric patients. Indicates continued studies on the effects of nicotine and related alkaloids on learning in animals will be employed and remarks "These studies have not been pursued sufficiently and require the attention of a full time technician."
Page 1: vqz71e00
Log in for more options!
AC~RDIOVASCULAR, PHARMCOLOGY and CHE~+ffSTRY
TN ro.
C
~ COi41MIT`hEE :
Dr. Cattell, Chm.
Dr. Wilson
Dr. Jacobson
Dr. Little
COUNCIL FOR TO1tACCO IZI:fi]:ARCR X. S. A.
SUCCE.tsOR f0 T11A
TOBi4CC0 INDUSTRY RI:SR/!RClf COAlh11T7EC
150 EAST FORTYSLCOND STREET
NEW YORX. N.Y. 20017
Renewal
Application For Research Grant
Dota APRX'L 28, 1964
1. Name of Investigrtor..
EDWARD F. DOMINO, M.D.
2. Title: Professor of Pharmacology
3. Institution
& Address:
4. Project or Subject:
The University of Michigan
64+0 Medical Science Building
Department of P:aarmacology
Ann Arbor, Michigan
EFFECTS OF NICOTINE ON THE CENTRAL NERVOUS SYSTEM
It is proposed to pursue our studies on the action of nicotine and its derivatives,
either metabolites or natural alkaloids, in tobacco, on the central nervous system of
animals and humans. The principal investigator feels that this is an extremely
important area of research for we have only scratched the surface in unfolding the
amazing effects of this alkaloid as described in the accompanying Progress Report #6.
Two major areas of research will be pursued.
(Application for a 3 - year period of support - January 1, 1965 to December 31, 1967)
C
5. Detailed Plan of Procedure (Use reverse side if additional space is required).
A. Behavioral and EEG Correlations in Animals and Man
06R6
Activated: 1/1/59
Renewed annually
on the anniversary
01127845
In the past six months two different behavioral and EEG actions of 5-10 micro~:gm/kg
doses of nicotine have been demonstrated in cats. The first acticn is a very mild
and transient wake-up effect in the sleeping cat. The second action is a sleep
promoting effect that is manifested by a"paradoxical" phase of EEG activity which
lasts about 15-30 minutes. In man this type of activity has been associated with
dreaming. In animals, it is also postulated to be a similar phenomenon as evidenced
by a) eyeball movement, b) altered blood pressure, c) respiration, d) pulse rate,
and e) activity. In animals, it,is proposed to study these effects of nicotine
and relaced alkaloids on EEG activity of the linbic system,.reticular and hypo-
thalamic activating systems and cerebral cortex before and after various bl ki
ocng
` drsbs in order to ascertain central and peripheral components of nicotine action.
These effects will be correlated with behavior through a oni-way window compartment.
Both gross behavior as well as instrumental conditioning will be studied. It is
proposed to obtain and study all of the known alkaloids of nicotine which are present
in tobacco smoke as well as critical metabolites such as 5+~cotinine, etc.
i~;: ..

Page 2: vqz71e00
Log in for more options!
2
5. (continued)
Similar studies using the scalp EEG and evoked potentials as an index of
arousal, sleep or dreaming will be carried out in a) normal human volunteers
and b) selected psychiatric patients with and without tranquilizers or medication.
It is a curious fact that many psychiatric patients smoke excessively. It is
our belief that they do so for the beneficial actions of nicotine in promoting
the "paradoxical" phase of sleep as well as its calming effect during wakefulness.
The role of nicotine will be.determined as a "wake-up" agent in sleeping patients
and as a promotor of the "paradoxical" phase of the EEG as associated with dreaming.
B. Effects of Nicotine and Related Alkaloids on Learning in Aninals.
Our studies on the effects of these agents on the acquisition of avoidance
learning in the rat will be pursued. Are these actions directly on the central
nervous system or a peripheral action due to a-fferent stimulation, catecholamine
serotonin release? These studies have not been pursued suff_ciently and require
the attention of a full time technician.
C
C

Page 3: vqz71e00
Log in for more options!
.. .. .,~.-
.
C
C
6. Budget Plan: L
a. Salaries (including ~ringe
for each year benefits, 12/.)
b. Expendable Supplies
c. Permanent Equipment
d. Overhead (15% of a, b, e)
.. Other
7. Anticipated Duration of Work: 3 years
$ 14,560
5.000
700
_2.A979
_300
Total ~ 2.3.,,532
8. Facilities and Staff Available:
A neuropharmacolooical laboratory is in operation under the direction of the
Principal Investigator. The funds for staff include salaries for Dr. Yamamoto
($6,000) and one full time ($4500) and one part time ($2500) technician. Some of
the funds f or supplies and equipment include remodeling costs for a room with
a one-way window, etc., for the human studies.
9. Additional Requirements:
The assistance of the Council for Tobacco 'Research is requ.ested for supplies
of (-)nicotine for human use as well as obtaining the minor alkaloids of tobacco
from various sources.
10. Additional Information (Including relation of work to other projects and other sources of
supply):
A 3-year request for funds is made to provide stability for the research
project. Funds are requested as follows:
$23,539
January 1, 1965 - December 31, 19%':;5 WSJ~ ~~:Q'+51
January 1, 1966 - December 31, 19466 24,000*
January 1, 1967 - December 31, 1967 25,000*
* 1966 and 1967 figures adjusted for estimated cost of living increases
on salaries.
Signature
Director of Project
Edward F. Domino, M.D.
Business Officer of & Institution
Harlah J. Wulder, Assistant Controller
